Bill Eldridge is an accomplished scientist with extensive experience in biotherapeutic discovery and development. Currently serving as Vice President of Biologics at Constructive Bio since February 2025, Bill has held prominent roles such as CEO and Chief Scientific Officer at Isogenica Limited from August 2020 to February 2025, and Senior Director of Alliances at the same company prior to that. Bill's consulting experience with B. Eldridge Consulting and tenure as CSO at Cyclogenix Limited further showcase a commitment to innovation in therapeutic applications. Earlier career milestones include co-inventing a novel in vitro display technology at Isogenica and significant contributions to antibody engineering at Cambridge Antibody Technology. Bill holds a PhD in Protein Engineering from the University of Kent and a BSc in Microbiology from the University of Surrey.
This person is not in any teams
This person is not in any offices